CeriBell, Inc. SEC Filings

Raymond Woo, Chief Technology Officer of Ceribell, Inc. (CBLL), reported option exercises and a sale executed under a Rule 10b5-1 trading plan on 09/04/2025. He exercised a stock option with a $2.24 exercise price for 1,472 shares, and two options with $4.70 exercise prices for 3,025 and 6,615 shares, respectively. Following those exercises his reported common stock beneficial ownership increased in interim steps to 178,816 shares and then, after a sale, decreased to 167,704 shares. He sold 11,112 shares at a weighted-average price of $12.11 (individual sale prices ranged $12.00–$12.34). The Form 4 states the option exercises and sales were effected pursuant to a Rule 10b5-1 plan and notes vesting schedules and exercisability for the reported options.

Rebecca B. Robertson, a director of Ceribell, Inc. (CBLL), reported a sale of 827 shares of the issuer's common stock on 09/03/2025 at a reported price of $11.36 per share under a Rule 10b5-1 trading plan. After the reported transaction Ms. Robertson beneficially owned 9,215 shares, held directly. The Form 4 was filed as a one-person filing and signed by an attorney-in-fact on behalf of the reporting person.

The filing states the sale was effected pursuant to a 10b5-1 plan, indicating the transaction was prearranged. No derivative transactions, option exercises, or additional securities classes are reported in this Form 4.

CeriBell, Inc. filed a Form 144 notifying the proposed sale of 11,112 common shares via Fidelity Brokerage Services on or about 09/04/2025 on the NASDAQ. The filing reports an aggregate market value of $134,609.87 against 36,663,968 shares outstanding, indicating the shares represent approximately 0.03% of the outstanding common stock. The shares arise from option exercises: 1,472 shares from an option granted 07/07/2021 and 9,640 shares from an option granted 02/16/2023, with cash payment recorded on 09/04/2025. The filer reports no sales in the prior three months. The form contains standard representations about material nonpublic information and signature attestation.

Ceribell, Inc. insider Raymond Woo, the company's Chief Technology Officer, exercised options under a Rule 10b5-1 plan on 09/02/2025. He acquired 20,000 shares of Common Stock by exercising stock options at a $2.24 exercise price. Following the transaction, the reporting person beneficially owns 167,704 shares of common stock and directly holds 20,000 underlying shares from the exercised option. The option granted is fully vested and exercisable and has an expiration date of 06/10/2029. The Form 4 was signed by an attorney-in-fact on 09/04/2025.

CeriBell, Inc. (CBLL) submitted a Form 144 notice showing a proposed sale of 827 common shares acquired through restricted stock vesting on 09/01/2025. The filing lists an approximate sale date of 09/03/2025 through Fidelity Brokerage Services, with an aggregate market value of $9,394.72 based on the filing. The issuer has 36,663,968 shares outstanding, per the form. The filer also disclosed recent sales by Rebecca B. Robertson: 20,000 shares sold on 06/16/2025 for $342,737.54 and 7,445 shares sold on 06/17/2025 for $131,267.25. The filing states the securities to be sold were received as compensation and that the signer represents no undisclosed material adverse information.

Ceribell insider sale reported on Form 4. Senior Vice President, Finance and PAO David Foehr sold 866 shares of Ceribell, Inc. (ticker CBLL) on 08/27/2025 at a weighted average price of $11.71. After the sale he is shown as beneficially owning 20,250 shares reported as direct ownership. The filing was signed by an attorney-in-fact on 08/29/2025. The form discloses the sale price range was $11.71–$11.72 and notes the reporting person will provide per-transaction detail upon request.

CeriBell, Inc. (CBLL) submitted a Form 144 reporting a proposed sale of 866 common shares, with an aggregate market value of $10,142.93. The shares are part of a restricted stock vesting acquired on 08/20/2025 and paid as compensation. The sale is planned through Fidelity Brokerage Services LLC on 08/27/2025 and the securities trade on NASDAQ. The filer certifies no undisclosed material adverse information about the issuer. There were no sales by the filer in the prior three months reported.

Ceribell, Inc. (CBLL) reporting person Joseph S. Manni, Chief Revenue Officer, disclosed a sale of 660 shares of common stock on 08/25/2025 at a reported price of $11.58 per share. After the transaction he beneficially owns 27,761 shares directly. The filing indicates a routine insider sale with remaining meaningful ownership by the officer.

Ceribell, Inc. insider sale disclosed. David Foehr, Senior VP, Finance and PAO and a company officer, sold 484 shares of Ceribell common stock on 08/25/2025 at $11.58 per share. After the sale he beneficially owns 21,116 shares. The Form 4 was signed by an attorney-in-fact on 08/27/2025, documenting the transaction and reporting compliance.